Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecas107452-89-1

107452-89-1

107452-89-1 structural image
Product Name: Ziconotide Polyacetate
Formula: C102H172N36O32S7
Synonyms: SNX-111;Ziconotide
Inquiry

CHEMICAL AND PHYSICAL PROPERTIES

Solubility Freely soluble in water and is practically insoluble in methyl tert-butyl ether
Stability/Shelf Life The results /of stability studies/ justify a retest period of 36 months when stored at -20 °C in the proposed packaging.
Other Experimental Properties Hydrophilic

SAFETY INFORMATION

Signal word Danger
Pictogram(s)

Skull and Crossbones
Acute Toxicity
GHS06
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P403+P233:Store in a well-ventilated place. Keep container tightly closed.

COMPUTED DESCRIPTORS

Molecular Weight 2639.2 g/mol
XLogP3 -14
Hydrogen Bond Donor Count 42
Hydrogen Bond Acceptor Count 46
Rotatable Bond Count 40
Exact Mass 2638.1016905 g/mol
Monoisotopic Mass 2637.0983357 g/mol
Topological Polar Surface Area 1310 Ų
Heavy Atom Count 177
Formal Charge 0
Complexity 5480
Isotope Atom Count 0
Defined Atom Stereocenter Count 22
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

PRODUCT INTRODUCTION

description

Ziconotide (also known as SNX-111) is a neurotoxic peptide derived from the cone snail Conus magus comprising 25 amino acids with three disulphide bonds. Other such peptides, collectively termed conotoxins, exist, and some have shown efficacy in binding specific subsets of calcium channels; ziconotide is used in part because it can be synthesized without loss of proper bond formation or structural elements. Ziconotide is used to manage severe chronic pain refractory to other methods, through its ability to inhibit N-type calcium channels involved in nociceptive signalling. Ziconotide was granted FDA approval on December 28, 2004 for marketing by TerSera therapeutics LLC. under the name Prialt. To date, ziconotide is the only calcium channel blocking peptide approved for use by the FDA.